PAPER Zhang K, Wang J, Peng G, Liu P, He F, Zhu Z, Luo B
SEARCH RESULTS
14055 RESULTS
PAPER Regan J, Frison E, Collin F, Dawes P, Hann M, Himmelsbach I, Hooper E, Reeves D, Simkin Z, Thodi C, Yang F, Leroi I, SENSE-Cog Trial Development Team
Individualised sensory intervention to improve quality of life in people with dementia and their companions (SENSE-Cog trial): study protocol for a randomised controlled trial.
Trials. 2019 Jan 25;20(1):80. PubMed: 30683150PAPER Marlats F, Djabelkhir-Jemmi L, Azabou E, Boubaya M, Pouwels S, Rigaud AS
Comparison of effects between SMR/delta-ratio and beta1/theta-ratio neurofeedback training for older adults with Mild Cognitive Impairment: a protocol for a randomized controlled trial.
Trials. 2019 Jan 29;20(1):88. PubMed: 30696475PAPER Femminella GD, Frangou E, Love SB, Busza G, Holmes C, Ritchie C, Lawrence R, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, Archer H, Coulthard E, Underwood BR, Prasanna A, Koranteng P, Karim S, Junaid K, McGuinness B, Nilforooshan R, Macharouthu A, Donaldson A, Thacker S, Russell G, Malik N, Mate V, Knight L, Kshemendran S, Harrison J, Brooks DJ, Passmore AP, Ballard C, Edison P
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).
Trials. 2019 Apr 3;20(1):191. PubMed: 30944040PAPER Belleville S, Moussard A, Ansaldo AI, Belchior P, Bherer L, Bier N, Bohbot VD, Bruneau MA, Cuddy LL, Gilbert B, Jokel R, Mahalingam K, McGilton K, Murphy KJ, Naglie G, Rochon E, Troyer AK, Anderson ND
Rationale and protocol of the ENGAGE study: a double-blind randomized controlled preference trial using a comprehensive cohort design to measure the effect of a cognitive and leisure-based intervention in older adults with a memory complaint.
Trials. 2019 May 22;20(1):282. PubMed: 31118095PAPER Cave AE, Chang DH, Münch GW, Steiner GZ
Efficacy of Cognition Support Formula® on cognitive function in older adults with subjective cognitive impairment: a protocol for a 26-week, randomised, double-blind, placebo-controlled trial.
Trials. 2019 Jun 10;20(1):345. PubMed: 31182153PAPER Shin HY, Kim JH, Jahng GH, Jung WS, Park SU, Ko CN, Park JM
The effectiveness and safety of Kami Guibi-tang for mild cognitive impairment: study protocol of a pilot, randomized, placebo-controlled, double-blind trial.
Trials. 2019 Jul 22;20(1):448. PubMed: 31331367PAPER Yue S, He T, Li B, Qu Y, Peng H, Chen J, Lei M, Chen C, Wu W
Effectiveness of Yi-Zhi-An-Shen granules on cognition and sleep quality in older adults with amnestic mild cognitive impairment: protocol for a randomized, double-blind, placebo-controlled trial.
Trials. 2019 Aug 20;20(1):518. PubMed: 31429790PAPER Kim JH, Cho MR, Park GC, Lee JS
Effects of different acupuncture treatment methods on mild cognitive impairment: a study protocol for a randomized controlled trial.
Trials. 2019 Sep 4;20(1):551. PubMed: 31484559PAPER Ayhan Y, Karadağ Çaman Ö, Karahan S, Kıran S, Saka E, Barışkın E, Bilir N
[A Population-Based Study for the Standardization of the Turkish Version of the Modified Mini Mental State Examination (3MS) and Assessment of Certain Environmental Risk Factors for Dementia: Methodology and Sample Characteristics].
Turk Psikiyatri Derg. 2018;29(4):238-247. PubMed: 30887474PAPER Roumiani ME, Dorosti N
Sonochemical synthesis of a nanodandelion tin(IV) complex with carbacylamidophosphate ligand as anti-Alzheimer agent: Molecular docking study.
Ultrason Sonochem. 2019 Jul;55:207-216. Epub 2019 Jan 23 PubMed: 30745233PAPER Toomsoo T, Liepelt-Scarfone I, Berg D, Kerner R, Pool AH, Kadastik-Eerme L, Rubanovits I, Asser T, Taba P
Effect of Age on Substantia Nigra Hyper-echogenicity in Parkinson's Disease Patients and Healthy Controls.
Ultrasound Med Biol. 2019 Jan;45(1):122-128. Epub 2018 Oct 26 PubMed: 30482710PAPER Cherrier MM, Higano CS
Impact of androgen deprivation therapy on mood, cognition, and risk for AD.
Urol Oncol. 2019 Mar 9; PubMed: 30862408PAPER Zhao B, Marciniuk K, Gibbs E, Yousefi M, Napper S, Cashman NR
Therapeutic vaccines for amyotrophic lateral sclerosis directed against disease specific epitopes of superoxide dismutase 1.
Vaccine. 2019 Aug 14;37(35):4920-4927. Epub 2019 Jul 16 PubMed: 31324499PAPER Koff WC, Schenkelberg T